LYVE1 and neoplasm: Metronomic DOX treatment also resulted in a significant decrease in lymphatic endothelial VEGFR-3 expression and LYVE-1+ tumor lymphatic vessel density in the WT but not Redd1−/− mice (Fig. 5h–j).